Q1 2025 Earnings Forecast for Encompass Health Co. (NYSE:EHC) Issued By William Blair

Encompass Health Co. (NYSE:EHC - Free Report) - William Blair raised their Q1 2025 earnings per share (EPS) estimates for shares of Encompass Health in a note issued to investors on Wednesday, April 24th. William Blair analyst J. Haase now expects that the company will post earnings per share of $1.30 for the quarter, up from their prior forecast of $1.03. William Blair currently has a "Outperform" rating on the stock. The consensus estimate for Encompass Health's current full-year earnings is $4.10 per share.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period last year, the company earned $0.88 EPS. The company's revenue for the quarter was up 13.4% on a year-over-year basis.

Several other research firms also recently weighed in on EHC. Barclays lifted their target price on Encompass Health from $101.00 to $108.00 and gave the company an "overweight" rating in a research report on Thursday. Stephens reiterated an "overweight" rating and issued a $85.00 price objective on shares of Encompass Health in a research note on Tuesday, January 16th. Mizuho increased their price objective on Encompass Health from $93.00 to $95.00 and gave the stock a "buy" rating in a research report on Thursday. Raymond James reiterated a "strong-buy" rating and issued a $95.00 price objective (up previously from $85.00) on shares of Encompass Health in a research report on Friday. Finally, Truist Financial upped their target price on Encompass Health from $82.00 to $86.00 and gave the company a "buy" rating in a report on Friday, February 9th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $88.13.

Encompass Health Trading Up 1.4 %

Shares of NYSE:EHC traded up $1.15 during midday trading on Monday, reaching $83.62. 537,945 shares of the company's stock were exchanged, compared to its average volume of 671,302. The firm's 50 day simple moving average is $78.45 and its two-hundred day simple moving average is $71.10. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.28. The stock has a market cap of $8.37 billion, a price-to-earnings ratio of 22.60, a P/E/G ratio of 1.34 and a beta of 0.94. Encompass Health has a fifty-two week low of $57.55 and a fifty-two week high of $85.84.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date was Thursday, March 28th. Encompass Health's dividend payout ratio is presently 16.22%.

Hedge Funds Weigh In On Encompass Health

Hedge funds have recently modified their holdings of the stock. New York State Teachers Retirement System grew its holdings in shares of Encompass Health by 6.8% during the first quarter. New York State Teachers Retirement System now owns 73,166 shares of the company's stock valued at $6,042,000 after buying an additional 4,670 shares in the last quarter. Horrell Capital Management Inc. grew its stake in Encompass Health by 0.5% in the first quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company's stock valued at $2,425,000 after purchasing an additional 147 shares in the last quarter. Equitable Trust Co. grew its stake in Encompass Health by 69.4% in the first quarter. Equitable Trust Co. now owns 6,429 shares of the company's stock valued at $531,000 after purchasing an additional 2,634 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Encompass Health by 75.7% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 720,173 shares of the company's stock valued at $59,472,000 after purchasing an additional 310,285 shares in the last quarter. Finally, Rice Hall James & Associates LLC grew its stake in Encompass Health by 15.1% in the first quarter. Rice Hall James & Associates LLC now owns 55,111 shares of the company's stock valued at $4,551,000 after purchasing an additional 7,225 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.